CSTL
Price:
$29.32
Market Cap:
$813.24M
Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company also offers DecisionDx-UM test, a proprietary GEP test that predicts the risk of metastasis for patients with uveal melanoma, a rare eye cancer; DecisionDx-SCC, a proprietary 40-gene expression profile test that uses an individual patient's tumor biology to predict individual risk of squamous cell carcinoma metastasis for patients with one or more risk f...[Read more]
Industry
Medical - Diagnostics & Research
IPO Date
2019-07-25
Stock Exchange
NASDAQ
Ticker
CSTL
According to Castle Biosciences, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 752.86M. This represents a change of 54.01% compared to the average of 488.85M of the last 4 quarters.
The mean historical Enterprise Value of Castle Biosciences, Inc. over the last ten years is 473.12M. The current 752.86M Enterprise Value has changed 15.81% with respect to the historical average. Over the past ten years (40 quarters), CSTL's Enterprise Value was at its highest in in the June 2021 quarter at 1.47B. The Enterprise Value was at its lowest in in the June 2018 quarter at 0.
Average
473.12M
Median
494.86M
Minimum
221.31M
Maximum
861.23M
Discovering the peaks and valleys of Castle Biosciences, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 289.15%
Maximum Annual Enterprise Value = 861.23M
Minimum Annual Increase = -33.38%
Minimum Annual Enterprise Value = 221.31M
Year | Enterprise Value | Change |
---|---|---|
2023 | 494.86M | -1.75% |
2022 | 503.67M | -33.38% |
2021 | 756.07M | -12.21% |
2020 | 861.23M | 289.15% |
2019 | 221.31M | -10.74% |
2018 | 247.94M | 9.33% |
The current Enterprise Value of Castle Biosciences, Inc. (CSTL) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
584.87M
5-year avg
567.43M
10-year avg
473.12M
Castle Biosciences, Inc.’s Enterprise Value is less than CareDx, Inc (1.36B), less than Twist Bioscience Corporation (2.00B), greater than Biodesix, Inc. (287.88M), less than Natera, Inc. (13.60B), greater than Genetron Holdings Limited (-48977790.00), less than Olink Holding AB (publ) (3.16B), greater than FONAR Corporation (91.27M), greater than Exagen Inc. (53.99M), greater than Personalis, Inc. (284.58M), less than Guardant Health, Inc. (3.23B), greater than Burning Rock Biotech Limited (-84455880.10), greater than Sera Prognostics, Inc. (231.60M), greater than LumiraDx Limited (377.41M), greater than Neuronetics, Inc. (43.46M), greater than Enzo Biochem, Inc. (2.73M),
Company | Enterprise Value | Market cap |
---|---|---|
1.36B | $1.43B | |
2.00B | $2.15B | |
287.88M | $268.58M | |
13.60B | $13.96B | |
-48977790.00 | $127.29M | |
3.16B | $3.24B | |
91.27M | $104.35M | |
53.99M | $54.59M | |
284.58M | $285.67M | |
3.23B | $2.92B | |
-84455880.10 | $48.03M | |
231.60M | $234.91M | |
377.41M | $0 | |
43.46M | $23.48M | |
2.73M | $57.63M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Castle Biosciences, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Castle Biosciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Castle Biosciences, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Castle Biosciences, Inc. (CSTL)?
What is the 3-year average Enterprise Value for Castle Biosciences, Inc. (CSTL)?
What is the 5-year average Enterprise Value for Castle Biosciences, Inc. (CSTL)?
How does the current Enterprise Value for Castle Biosciences, Inc. (CSTL) compare to its historical average?